| Trial ID: | L0315 |
| Source ID: | NCT00785629
|
| Associated Drug: |
Calcium Acetate
|
| Title: |
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00785629/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Calcium acetate|DRUG: Lanthanum Carbonate|DRUG: Sevelamer Carbonate|DRUG: Placebo
|
| Outcome Measures: |
Primary: Serum Phosphorus, mean serum phosphorus from months 3-9, months 3-9 |
|
| Sponsor/Collaborators: |
Sponsor: Denver Nephrologists, P.C. | Collaborators: Shire|Fresenius Medical Care North America|Genzyme, a Sanofi Company|Novartis Pharmaceuticals|DaVita Dialysis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
148
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2009-02
|
| Completion Date: |
2011-07
|
| Results First Posted: |
2012-10-30
|
| Last Update Posted: |
2012-10-30
|
| Locations: |
Denver Nephrologists, PC, Denver, Colorado, 80230, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00785629
|
